Skip to main content
COSMAX BTI, INC. logo

COSMAX BTI, INC. — Investor Relations & Filings

Ticker · 044820 ISIN · KR7044820009 LEI · 988400G29UNRG3TZ7888 KO Manufacturing
Filings indexed 521 across all filing types
Latest filing 2023-11-13 Earnings Release
Country KR South Korea
Listing KO 044820

About COSMAX BTI, INC.

https://www.cosmax.com/

COSMAX BTI, INC. is a global original design manufacturer (ODM) specializing in the research, development, and production of cosmetics, health functional foods, and pharmaceuticals. The company's portfolio includes a wide range of products such as basic and specialized skin care, health supplements, capsules, and medicines. Operating on an ODM model, COSMAX BTI provides comprehensive services to its clients, from initial formula development and research to final product manufacturing. The company also develops and produces specialized containers for its product lines, leveraging its advanced research and production facilities.

Recent filings

Filing Released Lang Actions
연결재무제표기준영업(잠정)실적(공정공시)
Earnings Release Classification · 100% confidence The document is a 'Provisional Earnings Report' (영업(잠정)실적) for Cosmax BTI, detailing quarterly financial performance (revenue, operating profit, net income) for Q3 2023. It provides key financial highlights and comparisons to previous periods. As it is an initial announcement of quarterly financial results, it fits the definition of an Earnings Release (ER). Q3 2023
2023-11-13 Korean
투자판단관련주요경영사항(자회사의 주요경영사항)(특허권 취득)
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from Cosmax BTI regarding a 'major management matter' (투자판단 관련 주요경영사항), specifically the acquisition of a patent. It follows the standard format for Korean regulatory disclosures (DART system style). Since it does not fit into specific categories like M&A, dividends, or financial reports, it falls under the general regulatory filing category.
2023-11-02 Korean
[기재정정]신규시설투자등(자회사의 주요경영사항)
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from Cosmax BTI regarding a 'New Facility Investment' (신규시설투자등). It specifically details a correction (정정신고) to a previous disclosure, updating the investment completion date due to design changes. Since this is a specific regulatory disclosure regarding capital expenditure and facility investment that does not fit into categories like M&A, dividends, or financial reports, it falls under the general regulatory filing category.
2023-08-31 Korean
반기보고서 (2023.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-annual Report) for COSMAX BTI, covering the period from January 1, 2023, to June 30, 2023. It contains comprehensive financial statements, management discussion, and corporate governance details, which aligns with the definition of an Interim/Quarterly Report (IR). H1 2023
2023-08-14 Korean
연결재무제표기준영업(잠정)실적(공정공시)
Earnings Release Classification · 100% confidence The document is a 'Provisional Earnings Release' (영업(잠정)실적) for Cosmax BTI, detailing key financial metrics like revenue, operating profit, and net income for the second quarter of 2023. It is a standard initial announcement of financial results, which fits the definition of an Earnings Release (ER). Q2 2023
2023-08-11 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Financial Supervisory Service in South Korea. This type of filing is a standard regulatory disclosure for insider holdings and transactions, which corresponds to the 'Director's Dealing' category in the provided schema.
2023-08-08 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.